Literature DB >> 2648256

Ph1+bcr- acute leukemias: implication of Alu sequences in a chromosomal translocation occurring in the new cluster region within the BCR gene.

S J Chen1, Z Chen, L d'Auriol, M Le Coniat, D Grausz, R Berger.   

Abstract

Chromosomal breakpoints on chromosome 22 are located in the first intron of the bcr gene in half of the Philadelphia-positive acute leukemias (Ph1+bcr- AL). We have previously shown that, in these cases, the breakpoints are clustered in the 3' portion of the bcr gene first intron, particularly in a region called bcr2 or m-bcr-1. In order to search for mechanisms underlying the reciprocal chromosome translocation, molecular analysis of breakpoints on chromosome 9 and 22 were performed in a Ph1+bcr- acute lymphoblastic leukemia with bcr2 rearrangement. The comparison of rearranged sequences with their normal counterparts showed that human repetitive Alu sequences were physically linked to the translocation on both chromosomes. In addition an inverted Alu repeat was found 5' to each rearranged Alu sequence on chromosome 22 and 9, with an intervening sequence of 210 and 90bp respectively. This allows to propose a new model, still to be confirmed, of recombination after formation of two hairpin structures which could facilitate the genesis of the chromosomal accident.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2648256

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  12 in total

1.  Prototypic sequences for human repetitive DNA.

Authors:  J Jurka; J Walichiewicz; A Milosavljevic
Journal:  J Mol Evol       Date:  1992-10       Impact factor: 2.395

Review 2.  Molecular analysis of the Philadelphia chromosome.

Authors:  A Dobrovic; G B Peters; J H Ford
Journal:  Chromosoma       Date:  1991-09       Impact factor: 4.316

3.  Neural network detects errors in the assignment of mRNA splice sites.

Authors:  S Brunak; J Engelbrecht; S Knudsen
Journal:  Nucleic Acids Res       Date:  1990-08-25       Impact factor: 16.971

4.  Identification and characterization of new human medium reiteration frequency repeats.

Authors:  J Jurka; D J Kaplan; C H Duncan; J Walichiewicz; A Milosavljevic; G Murali; J F Solus
Journal:  Nucleic Acids Res       Date:  1993-03-11       Impact factor: 16.971

5.  Structural alterations of the BCR and ABL genes in Ph1 positive acute leukemias with rearrangements in the BCR gene first intron: further evidence implicating Alu sequences in the chromosome translocation.

Authors:  S J Chen; Z Chen; M P Font; L d'Auriol; C J Larsen; R Berger
Journal:  Nucleic Acids Res       Date:  1989-10-11       Impact factor: 16.971

6.  Saccharomyces cerevisiae as a model system to define the chromosomal instability phenotype.

Authors:  Christopher D Putnam; Vincent Pennaneach; Richard D Kolodner
Journal:  Mol Cell Biol       Date:  2005-08       Impact factor: 4.272

7.  Activation of RNA polymerase III transcription of human Alu repetitive elements by adenovirus type 5: requirement for the E1b 58-kilodalton protein and the products of E4 open reading frames 3 and 6.

Authors:  B Panning; J R Smiley
Journal:  Mol Cell Biol       Date:  1993-06       Impact factor: 4.272

8.  Chromosome translocation based on illegitimate recombination in human tumors.

Authors:  J Zucman-Rossi; P Legoix; J M Victor; B Lopez; G Thomas
Journal:  Proc Natl Acad Sci U S A       Date:  1998-09-29       Impact factor: 11.205

9.  Chromosomal translocations joining LCK and TCRB loci in human T cell leukemia.

Authors:  B Tycko; S D Smith; J Sklar
Journal:  J Exp Med       Date:  1991-10-01       Impact factor: 14.307

10.  Accelerated evolution of the ASPM gene controlling brain size begins prior to human brain expansion.

Authors:  Natalay Kouprina; Adam Pavlicek; Ganeshwaran H Mochida; Gregory Solomon; William Gersch; Young-Ho Yoon; Randall Collura; Maryellen Ruvolo; J Carl Barrett; C Geoffrey Woods; Christopher A Walsh; Jerzy Jurka; Vladimir Larionov
Journal:  PLoS Biol       Date:  2004-03-23       Impact factor: 8.029

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.